Effects of a low-threshold Substitution Therape of Opioid-dependent Patients during the Corona Crisis (COVID-19)

Effects of a low-threshold Substitution Therape of Opioid-dependent Patients during the Corona Crisis (COVID-19) - STOP CC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023401

Enrollment

Registered

2020-11-30

Start date

2020-10-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F11.2

Interventions

Group 1: The effects of a specialized concept of the substitution therapy of opioid dependent patients during the corona crisis is being studied. In addition to the regular data from treatment, there

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Opioid dependency (ICD-10). 18 years of age. Already patient in the substitution clinic of Drob Inn

Exclusion criteria

Exclusion criteria: No sufficient communication possible

Design outcomes

Primary

Measure	Time frame
The effects of a specialized concept of the substitution therapy of opioid dependent patients during the corona crisis is being studied. In addition to the regular data from treatment, there are two surveys. T1 is being done between October and December of 2020, T2 is planned for 6 months after T1. Social aspects, drug consumption, psychological symptoms (BSI-18), physical symptoms (OTI-Health-Score), the quality of life (OSTQOL), as well as the COVID-19-status are being researched. The goal is to research if the simplified, in Germany not yet used concept of treatment results in a significant change in the topics mentioned. The results could help to treat patients with a scientifically proven concept in future crisises or times of need.	—

Measure

Time frame

The effects of a specialized concept of the substitution therapy of opioid dependent patients during the corona crisis is being studied. In addition to the regular data from treatment, there are two surveys. T1 is being done between October and December of 2020, T2 is planned for 6 months after T1. Social aspects, drug consumption, psychological symptoms (BSI-18), physical symptoms (OTI-Health-Score), the quality of life (OSTQOL), as well as the COVID-19-status are being researched. The goal is to research if the simplified, in Germany not yet used concept of treatment results in a significant change in the topics mentioned. The results could help to treat patients with a scientifically proven concept in future crisises or times of need.

—

Countries

Germany

Contacts

Public ContactFabian Vorberg

Drob Inn

vorberg@jugendhilfe.de040 39993 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026